Case Report
Published on 20 Nov 2025
Subacute Paget–Schroetter with rapid recurrence and concurrent pulmonary emboli: a case report
in Vascular Surgery
Frontiers in Surgery
doi 10.3389/fsurg.2025.1705410
- 870 views
17 articles related to "Rapid Recurrence"
Articles
Case Report
Published on 04 Jun 2025
Treatment strategies for rapid recurrence and progression after surgery for stage I pulmonary pleomorphic carcinoma: a case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1547872
- 3,025 views
- 1 citation
Case Report
Published on 18 Aug 2022
Case report: Rapid recurrence of a chronic subdural haematoma associated with prostate cancer metastasis to a haematoma capsule
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.988779
- 2,002 views
Original Research
Published on 31 Jan 2020
LncRNA LUCRC Regulates Colorectal Cancer Cell Growth and Tumorigenesis by Targeting Endoplasmic Reticulum Stress Response
in RNA
Frontiers in Genetics
doi 10.3389/fgene.2019.01409
- 6,836 views
- 22 citations
Case Report
Published on 08 Sep 2021
Case Report and Literature Review: Pulmonary Sclerosing Pneumocytoma With Multiple Metastases Harboring AKT1 E17K Somatic Mutation and TP53 C176Y Germline Mutation
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2021.655574
- 3,812 views
- 10 citations
Case Report
Published on 29 May 2025
Case Report: ALK-rearranged mesenchymal neoplasms with S100 and CD34 co-expression: additional cases with distinct characteristics
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1516491
- 2,030 views
Case Report
Published on 15 Nov 2022
Delineation of molecular characteristics in pediatric PFA ependymoma involving rare osseous and pulmonary metastases: A case report and literature review
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1001118
- 2,750 views
- 3 citations
Case Report
Published on 28 Apr 2025
Iodine-125 seeds combined with anlotinib in the treatment of recurrent retroperitoneal liposarcoma after surgery: a case report
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1540868
- 1,570 views
- 3 citations
Case Report
Accepted on 11 Feb 2026
Case Report: Rapid Recurrence of Psoriasiform Dermatitis upon Sequential Anti-PD-1 Therapy with Pembrolizumab and Tislelizumab with 3-Year Follow-up
in Immunological Memory
Frontiers in Immunology
Case Report
Published on 13 Jan 2025
Case report: Intra-abdominal inflammatory myofibroblastic tumor with mucinous features: a case of rapid recurrence and dissemination post-surgery
in Cancer Imaging and Image-directed Interventions
Frontiers in Oncology
doi 10.3389/fonc.2024.1517710
- 1,690 views
- 2 citations
Case Report
Published on 12 Feb 2025
A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1544604
- 3,206 views
- 1 citation
Case Report
Published on 19 Jun 2025
Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1602870
- 2,465 views
- 3 citations
Case Report
Published on 20 Jan 2026
Case Report: A rare and recurrent case of primary corneal keratosis: diagnostic and therapeutic challenges
in Ophthalmology
Frontiers in Medicine
doi 10.3389/fmed.2025.1678333
- 463 views
Original Research
Published on 21 Feb 2022
Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2022.841819
- 4,919 views
- 15 citations
Review
Published on 15 Oct 2018
A Critical Overview of Targeted Therapies for Glioblastoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2018.00419
- 49,341 views
- 222 citations
Case Report
Published on 14 Feb 2022
Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring PRRC2B-ALK Rearrangement: A Case Report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.761558
- 4,599 views
- 29 citations